{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T02:46:38Z","timestamp":1791859598253,"version":"4.3.4"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:00:00Z","timestamp":1707955200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"1+X Clinical technology improvement of the Second hospital of Dalian Medical University","award":["202112"],"award-info":[{"award-number":["202112"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Hypertension influences the inflammatory pathological changes in the retina. The function of the inflammasomes is significant. To see if Sirtuin 1 (SIRT1) regulates angiotensin II (Ang II)-induced hypertensive retinopathy and inflammation by modulating NOD-like receptor thermal protein domain associated protein 3 (NLRP3) inflammasome activation and the potential protective effects of fucoidan (FO) in mouse retinal vascular endothelial cells (mRECs) and mice retina.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The diagnosis of hypertensive retinopathy was made after three weeks of Ang II infusion (3000\u00a0ng\/kg\/min). One day prior to the commencement of Ang II infusion, the mice were treatment with NLRP3 inhibitor MCC950 (10\u00a0mg\/kg\/day, intraperitoneal injections) or FO (300\u00a0mg\/kg\/day, oral gavage). A blood pressure was recorded. Hematoxylin and eosin (H&amp;E) staining was used to conduct pathological alterations, dihydroethidium bromide (DHE) was utilized to assess oxidative stress damage in the retina, and fluorescence angiography was used to identify vascular disorders in the eye. Using immunohistochemical labeling, NLRP3 expression was found. Reactive protein and mRNA expression levels in mouse retina and cells were assessed using Western blot and real-time quantitative polymerase chain reaction (RT-qPCR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NLRP3 inflammasome activation and SIRT1 decrease were brought about by Ang II infusion. Retinopathy and dysfunction were lessened by MCC950 target-induced NLRP3 inflammasome activation, while overexpression of SIRT1 had the opposite impact on NLRP3 inflammasome activation, indicating that SIRT1 functions as an upstream regulator of NLRP3 activity. FO may improve SIRT1 expression and decrease NLRP3 activation in retinopathy and dysfunction brought on by Ang II, and the effects were consistent across both in vivo and in vitro models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>SIRT1 adversely regulates the NLRP3 inflammasome pathway, which in turn increases Ang II-induced inflammation and hypertensive retinopathy. FO may mitigate Ang II-induced retinopathy and dysfunction via modulating the expression of SIRT1\/NLRP3. This implies practical approaches to the management of hypertensive retinopathy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12967-024-04877-6","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T02:02:50Z","timestamp":1707962570000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Fucoidan modulates SIRT1 and NLRP3 to alleviate hypertensive retinopathy: in vivo and in vitro insights"],"prefix":"10.1186","volume":"22","author":[{"given":"Jing","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaochen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huangzhao","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9142-6095","authenticated-orcid":false,"given":"Shuai","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,15]]},"reference":[{"issue":"1","key":"4877_CR1","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/j.ymthe.2019.09.025","volume":"28","author":"S Wang","year":"2020","unstructured":"Wang S, Li J, Wang T, et al. Ablation of immunoproteasome \u03b25i subunit suppresses hypertensive retinopathy by blocking ATRAP degradation in mice. Mol Ther. 2020;28(1):279\u201392.","journal-title":"Mol Ther"},{"issue":"1","key":"4877_CR2","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/ceo.12905","volume":"45","author":"S Fraser-Bell","year":"2017","unstructured":"Fraser-Bell S, Symes R, Vaze A. Hypertensive eye disease: a review. Clin Exp Ophthalmol. 2017;45(1):45\u201353.","journal-title":"Clin Exp Ophthalmol"},{"issue":"5","key":"4877_CR3","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cjca.2020.01.013","volume":"36","author":"L Xiao","year":"2020","unstructured":"Xiao L, Harrison DG. Inflammation in hypertension. Can J Cardiol. 2020;36(5):635\u201347.","journal-title":"Can J Cardiol"},{"issue":"8","key":"4877_CR4","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1016\/j.tips.2022.04.003","volume":"43","author":"RC Coll","year":"2022","unstructured":"Coll RC, Schroder K, Pelegr\u00edn P. NLRP3 and pyroptosis blockers for treating inflammatory diseases. Trends Pharmacol Sci. 2022;43(8):653\u201368.","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"4877_CR5","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1038\/s41423-021-00740-6","volume":"18","author":"Y Huang","year":"2021","unstructured":"Huang Y, Xu W, Zhou R. NLRP3 inflammasome activation and cell death. Cell Mol Immunol. 2021;18(9):2114\u201327.","journal-title":"Cell Mol Immunol"},{"issue":"1","key":"4877_CR6","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s13024-020-00372-w","volume":"15","author":"H Chen","year":"2020","unstructured":"Chen H, Deng Y, Gan X, et al. NLRP12 collaborates with NLRP3 and NLRC4 to promote pyroptosis inducing ganglion cell death of acute glaucoma. Mol Neurodegener. 2020;15(1):26.","journal-title":"Mol Neurodegener"},{"key":"4877_CR7","doi-asserted-by":"publisher","first-page":"175909142110181","DOI":"10.1177\/17590914211018100","volume":"13","author":"R Bai","year":"2021","unstructured":"Bai R, Lang Y, Shao J, Deng Y, Refuhati R, Cui L. The role of NLRP3 inflammasome in cerebrovascular diseases pathology and possible therapeutic targets. ASN Neuro. 2021;13:17590914211018100.","journal-title":"ASN Neuro"},{"issue":"20","key":"4877_CR8","doi-asserted-by":"publisher","first-page":"4693","DOI":"10.3390\/molecules25204693","volume":"25","author":"JCD Tomani","year":"2020","unstructured":"Tomani JCD, Kagisha V, Tchinda AT, et al. The inhibition of NLRP3 inflammasome and IL-6 production by Hibiscus noldeae Baker f. derived constituents provides a link to its anti-inflammatory therapeutic potentials. Molecules. 2020;25(20):4693.","journal-title":"Molecules."},{"issue":"1","key":"4877_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12929-021-00724-8","volume":"28","author":"SS Faria","year":"2021","unstructured":"Faria SS, Costantini S, de Lima VCC, et al. NLRP3 inflammasome-mediated cytokine production and pyroptosis cell death in breast cancer. J Biomed Sci. 2021;28(1):26.","journal-title":"J Biomed Sci"},{"key":"4877_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.3389\/fphar.2015.00262","volume":"6","author":"BZ Shao","year":"2015","unstructured":"Shao BZ, Xu ZQ, Han BZ, Su DF, Liu C. NLRP3 inflammasome and its inhibitors: a review. Front Pharmacol. 2015;6:262.","journal-title":"Front Pharmacol"},{"issue":"3","key":"4877_CR11","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1080\/00207454.2019.1679810","volume":"130","author":"S Wang","year":"2020","unstructured":"Wang S, Yao Q, Wan Y, et al. Adiponectin reduces brain injury after intracerebral hemorrhage by reducing NLRP3 inflammasome expression. Int J Neurosci. 2020;130(3):301\u20138.","journal-title":"Int J Neurosci"},{"key":"4877_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2020.113863","volume":"175","author":"D Liu","year":"2020","unstructured":"Liu D, Zeng X, Li X, et al. Advances in the molecular mechanisms of NLRP3 inflammasome activators and inactivators. Biochem Pharmacol. 2020;175: 113863.","journal-title":"Biochem Pharmacol"},{"key":"4877_CR13","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.3389\/fimmu.2019.01511","volume":"10","author":"BI Arioz","year":"2019","unstructured":"Arioz BI, Tastan B, Tarakcioglu E, et al. Melatonin attenuates LPS-induced acute depressive-like behaviors and microglial NLRP3 inflammasome activation through the SIRT1\/Nrf2 pathway. Front Immunol. 2019;10:1511.","journal-title":"Front Immunol"},{"issue":"6","key":"4877_CR14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0067532","volume":"8","author":"Y Li","year":"2013","unstructured":"Li Y, Xu S, Jiang B, Cohen RA, Zang M. Activation of sterol regulatory element binding protein and NLRP3 inflammasome in atherosclerotic lesion development in diabetic pigs. PLoS ONE. 2013;8(6): e67532.","journal-title":"PLoS ONE"},{"issue":"5","key":"4877_CR15","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.tem.2006.04.002","volume":"17","author":"T Yang","year":"2006","unstructured":"Yang T, Fu M, Pestell R, Sauve AA. SIRT1 and endocrine signaling. Trends Endocrinol Metab. 2006;17(5):186\u201391.","journal-title":"Trends Endocrinol Metab"},{"issue":"5","key":"4877_CR16","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.1007\/s10753-020-01242-9","volume":"43","author":"V Singh","year":"2020","unstructured":"Singh V, Ubaid S. Role of silent information regulator 1 (SIRT1) in regulating oxidative stress and inflammation. Inflammation. 2020;43(5):1589\u201398.","journal-title":"Inflammation"},{"key":"4877_CR17","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.redox.2018.02.013","volume":"16","author":"Y Han","year":"2018","unstructured":"Han Y, Xu X, Tang C, et al. Reactive oxygen species promote tubular injury in diabetic nephropathy: the role of the mitochondrial ros-txnip-nlrp3 biological axis. Redox Biol. 2018;16:32\u201346.","journal-title":"Redox Biol"},{"key":"4877_CR18","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/j.ijbiomac.2018.02.072","volume":"112","author":"Y Zheng","year":"2018","unstructured":"Zheng Y, Liu T, Wang Z, Xu Y, Zhang Q, Luo D. Low molecular weight fucoidan attenuates liver injury via SIRT1\/AMPK\/PGC1\u03b1 axis in db\/db mice. Int J Biol Macromol. 2018;112:929\u201336.","journal-title":"Int J Biol Macromol"},{"issue":"7","key":"4877_CR19","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1021\/np030096l","volume":"66","author":"DJ Newman","year":"2003","unstructured":"Newman DJ, Cragg GM, Snader KM. Natural products as sources of new drugs over the period 1981\u20132002. J Nat Prod. 2003;66(7):1022\u201337.","journal-title":"J Nat Prod"},{"issue":"11","key":"4877_CR20","doi-asserted-by":"publisher","first-page":"620","DOI":"10.3390\/md19110620","volume":"19","author":"Y Li","year":"2021","unstructured":"Li Y, Zheng Y, Zhang Y, et al. Brown algae carbohydrates: structures, pharmaceutical properties, and research challenges. Mar Drugs. 2021;19(11):620.","journal-title":"Mar Drugs"},{"issue":"3","key":"4877_CR21","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3390\/md14030042","volume":"14","author":"L Cunha","year":"2016","unstructured":"Cunha L, Grenha A. Sulfated seaweed polysaccharides as multifunctional materials in drug delivery applications. Mar Drugs. 2016;14(3):42.","journal-title":"Mar Drugs"},{"issue":"10","key":"4877_CR22","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.3390\/nu12103068","volume":"12","author":"WC Yu","year":"2020","unstructured":"Yu WC, Huang RY, Chou TC. Oligo-fucoidan improves diabetes-induced renal fibrosis via activation of Sirt-1, GLP-1R, and Nrf2\/HO-1: an in vitro and in vivo study. Nutrients. 2020;12(10):3068.","journal-title":"Nutrients"},{"key":"4877_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2022.102438","volume":"56","author":"S Wang","year":"2022","unstructured":"Wang S, Bai J, Zhang YL, et al. CXCL1-CXCR2 signalling mediates hypertensive retinopathy by inducing macrophage infiltration. Redox Biol. 2022;56: 102438.","journal-title":"Redox Biol"},{"key":"4877_CR24","doi-asserted-by":"publisher","first-page":"1164333","DOI":"10.3389\/fphar.2023.1164333","volume":"14","author":"S Wang","year":"2023","unstructured":"Wang S, Bai J, Che Y, Qu W, Li J. Fucoidan inhibits apoptosis and improves cardiac remodeling by inhibiting p53 transcriptional activation through USP22\/Sirt 1. Front Pharmacol. 2023;14:1164333.","journal-title":"Front Pharmacol"},{"key":"4877_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112133","volume":"143","author":"L Zhang","year":"2021","unstructured":"Zhang L, Jiang YH, Fan C, et al. MCC950 attenuates doxorubicin-induced myocardial injury in vivo and in vitro by inhibiting NLRP3-mediated pyroptosis. Biomed Pharmacother. 2021;143: 112133.","journal-title":"Biomed Pharmacother"},{"key":"4877_CR26","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.redox.2018.02.022","volume":"16","author":"S Wang","year":"2018","unstructured":"Wang S, Li J, Bai J, et al. The immunoproteasome subunit LMP10 mediates angiotensin II-induced retinopathy in mice. Redox Biol. 2018;16:129\u201338.","journal-title":"Redox Biol"},{"issue":"9","key":"4877_CR27","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.3109\/13880209.2014.982298","volume":"53","author":"SM Zhang","year":"2015","unstructured":"Zhang SM, Xie ZP, Xu ML, Shi LF. Cardioprotective effects of fucoidan against hypoxia-induced apoptosis in H9c2 cardiomyoblast cells. Pharm Biol. 2015;53(9):1352\u20137.","journal-title":"Pharm Biol"},{"issue":"3","key":"4877_CR28","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1167\/iovs.64.3.16","volume":"64","author":"L Lian","year":"2023","unstructured":"Lian L, Le Z, Wang Z, et al. SIRT1 inhibits high glucose-induced TXNIP\/NLRP3 inflammasome activation and cataract formation. Invest Ophthalmol Vis Sci. 2023;64(3):16.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"4877_CR29","doi-asserted-by":"publisher","first-page":"571","DOI":"10.3390\/md17100571","volume":"17","author":"HJ Fitton","year":"2019","unstructured":"Fitton HJ, Stringer DS, Park AY, Karpiniec SN. Therapies from fucoidan: new developments. Mar Drugs. 2019;17(10):571.","journal-title":"Mar Drugs"},{"issue":"2 Pt 2","key":"4877_CR30","doi-asserted-by":"publisher","first-page":"103S","DOI":"10.1093\/ajh\/4.2.103S","volume":"4","author":"AE Doyle","year":"1991","unstructured":"Doyle AE. Hypertension and vascular disease. Am J Hypertens. 1991;4(2 Pt 2):103S-106S.","journal-title":"Am J Hypertens"},{"issue":"18","key":"4877_CR31","first-page":"6424","volume":"26","author":"E Di Marco","year":"2022","unstructured":"Di Marco E, Aiello F, Lombardo M, et al. A literature review of hypertensive retinopathy: systemic correlations and new technologies. Eur Rev Med Pharmacol Sci. 2022;26(18):6424\u201343.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"4","key":"4877_CR32","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/hr.2010.263","volume":"34","author":"JB Lopes de Faria","year":"2011","unstructured":"Lopes de Faria JB, Silva KC, Lopes de Faria JM. The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress. Hypertens Res. 2011;34(4):413\u201322.","journal-title":"Hypertens Res."},{"key":"4877_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/OPTO.S183492","volume":"12","author":"M Tsukikawa","year":"2020","unstructured":"Tsukikawa M, Stacey AW. A review of hypertensive retinopathy and chorioretinopathy. Clin Optom (Auckl). 2020;12:67\u201373.","journal-title":"Clin Optom (Auckl)"},{"key":"4877_CR34","volume-title":"Hypertensive retinopathy","author":"P Modi","year":"2023","unstructured":"Modi P, Arsiwalla T. Hypertensive retinopathy. Treasure Island: StatPearls Publishing; 2023."},{"key":"4877_CR35","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.935135","volume":"28","author":"J Dziedziak","year":"2022","unstructured":"Dziedziak J, Zaleska-\u017bmijewska A, Szaflik JP, Cudnoch-J\u0119drzejewska A. Impact of arterial hypertension on the eye: a review of the pathogenesis, diagnostic methods, and treatment of hypertensive retinopathy. Med Sci Monit. 2022;28: e935135.","journal-title":"Med Sci Monit"},{"issue":"3","key":"4877_CR36","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.3390\/ijms22031064","volume":"22","author":"C De Miguel","year":"2021","unstructured":"De Miguel C, Pelegr\u00edn P, Baroja-Mazo A, Cuevas S. Emerging role of the inflammasome and pyroptosis in hypertension. Int J Mol Sci. 2021;22(3):1064.","journal-title":"Int J Mol Sci"},{"issue":"9","key":"4877_CR37","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1038\/s41419-020-02985-x","volume":"11","author":"B Bai","year":"2020","unstructured":"Bai B, Yang Y, Wang Q, et al. NLRP3 inflammasome in endothelial dysfunction. Cell Death Dis. 2020;11(9):776.","journal-title":"Cell Death Dis"},{"issue":"1","key":"4877_CR38","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3390\/ijms23010340","volume":"23","author":"F Burger","year":"2021","unstructured":"Burger F, Baptista D, Roth A, et al. NLRP3 inflammasome activation controls vascular smooth muscle cells phenotypic switch in atherosclerosis. Int J Mol Sci. 2021;23(1):340.","journal-title":"Int J Mol Sci"},{"key":"4877_CR39","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.2147\/JIR.S308177","volume":"14","author":"N Ji","year":"2021","unstructured":"Ji N, Qi Z, Wang Y, et al. Pyroptosis: a new regulating mechanism in cardiovascular disease. J Inflamm Res. 2021;14:2647\u201366.","journal-title":"J Inflamm Res"},{"key":"4877_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.801337","volume":"13","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, Zhang H, Li S, Huang K, Jiang L, Wang Y. Metformin alleviates LPS-induced acute lung injury by regulating the SIRT1\/NF-\u03baB\/NLRP3 pathway and inhibiting endothelial cell pyroptosis. Front Pharmacol. 2022;13: 801337.","journal-title":"Front Pharmacol"},{"key":"4877_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.639165","volume":"12","author":"J Guo","year":"2021","unstructured":"Guo J, Wang R, Liu D. Bone marrow-derived mesenchymal stem cells ameliorate sepsis-induced acute kidney injury by promoting mitophagy of renal tubular epithelial cells via the SIRT1\/Parkin axis. Front Endocrinol (Lausanne). 2021;12: 639165.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"4877_CR42","doi-asserted-by":"publisher","first-page":"bqac014","DOI":"10.1210\/endocr\/bqac014","volume":"163","author":"Y Huang","year":"2022","unstructured":"Huang Y, Yong P, Dickey D, Vora SM, Wu H, Bernlohr DA. Inflammasome activation and pyroptosis via a lipid-regulated SIRT1-p53-ASC axis in macrophages from male mice and humans. Endocrinology. 2022;163(4):bqac014.","journal-title":"Endocrinology."},{"key":"4877_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/iwj.14239","author":"W Wen","year":"2023","unstructured":"Wen W, Yang L, Wang X, et al. Fucoidan promotes angiogenesis and accelerates wound healing through AKT\/Nrf2\/HIF-1\u03b1 signalling pathway. Int Wound J. 2023. https:\/\/doi.org\/10.1111\/iwj.14239.","journal-title":"Int Wound J"},{"key":"4877_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.carres.2018.07.001","volume":"466","author":"Z Zhu","year":"2018","unstructured":"Zhu Z, Zhu B, Ai C, et al. Development and application of a HPLC-MS\/MS method for quantitation of fucosylated chondroitin sulfate and fucoidan in sea cucumbers. Carbohydr Res. 2018;466:11\u20137.","journal-title":"Carbohydr Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-04877-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-024-04877-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-024-04877-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,18]],"date-time":"2024-02-18T18:15:16Z","timestamp":1708280116000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-024-04877-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,15]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["4877"],"URL":"https:\/\/doi.org\/10.1186\/s12967-024-04877-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,15]]},"assertion":[{"value":"9 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"155"}}